Diagnostics News and Research

RSS

WARFARIN Study initiated to assess utility of genetic testing to reduce warfarin-related adverse events

Iverson Genetic Diagnostics, Inc. announced that the WARFARIN Study was initiated at Colorado Heart & Vascular, P.C. in Denver and other major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events.

30 Jul 2011

Human kinome RNAi screening performed using Roche’s xCELLigence MP Instrument

RNA interference studies are a powerful technology for high-throughput screening. However, endpoint analyses only provide a snapshot of the analyzed cellular phenotype, as it is not possible to measure developmental changes over time.

29 Jul 2011

Studies reveal new set of mutations linked with head and neck cancer

Powerful new technologies that zoom in on the connections between human genes and diseases have illuminated the landscape of cancer, singling out changes in tumor DNA that drive the development of certain types of malignancies such as melanoma or ovarian cancer.

29 Jul 2011

NanoString introduces new assay for leukemia fusion gene analysis

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the availability of a comprehensive multiplexed assay for the simple and cost-effective analysis of fusion genes linked to leukemia.

From NanoString Technologies 29 Jul 2011

NeuroMetrix second quarter total revenues decrease to $2.6 million

NeuroMetrix, Inc., a science-based health care company improving patient care through neurotechnology, today reported business and financial highlights for the quarter and six months ended June 30, 2011.

28 Jul 2011

GE's Innova imaging systems maintain quality at lower dose rates under live fluoroscopy

As the number of interventional procedures to diagnose and treat patients increases worldwide, and the procedures grow in complexity and length, exposure to radiation is a growing concern for both clinicians and patients.

28 Jul 2011

UM researchers unravel genomic code of German E. coli bacteria

A team led by University of Maryland School of Medicine Institute for Genome Sciences researchers has unraveled the genomic code of the E. coli bacteria that caused the ongoing deadly outbreak in Germany that began in May 2011.

28 Jul 2011

Biosign closes brokered private placement for $1,900,000

Biosign Technologies Inc. announced today the closing of a brokered private placement of units of the Company for gross proceeds of approximately $1,900,000.

28 Jul 2011

Thermo Fisher Scientific second quarter revenues increase 12% to record $2.90 billion

Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the second quarter ended July 2, 2011.

From Thermo Fisher Scientific Inc. 27 Jul 2011

Safeguard Scientifics reports consolidated net income of $121.8M for second quarter 2011

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced results of operations for the second quarter of 2011.

27 Jul 2011

OICR to receive Government of Ontario grant for important cancer research

The Ontario Institute for Cancer Research (OICR) will receive $420 million over five years from the Government of Ontario to continue its research into the prevention, early detection, diagnosis and treatment of cancer.

27 Jul 2011

New silicone chip could make genetic analysis far more sensitive, rapid, and cost-effective

UBC researchers have invented a silicone chip that could make genetic analysis far more sensitive, rapid, and cost-effective by allowing individual cells to fall into place like balls in a pinball machine.

27 Jul 2011

Abbott announces research confirming presence of lutein in key regions of the infant brain

Preliminary new research demonstrates for the first time that lutein, an important phytonutrient (plant-based nutrient) that supports eye health, is the predominant carotenoid present in key areas of the infant brain, including areas that regulate overall brain function, cognition, vision, hearing and speech. This new research, supported by Abbott, was presented by Elizabeth Johnson, PhD, a scientist in the Carotenoids and Health Laboratory at Tufts University, at the 16th International Symposium on Carotenoids, in Krakow, Poland.

26 Jul 2011

Debiopharm, INC Research partner for clinical development programmes

INC Research, LLC, a therapeutically focused contract research organisation (CRO) with a trusted process for delivering reliable results, and Debiopharm Group, a Swiss-based global biopharmaceutical group with a focus on drug development and companion diagnostics, today announced a strategic partnership.

26 Jul 2011

Phadia demonstrates ImmunoCAP Molecular Allergy testing at AACC 2011

Today, at the 2011 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, Phadia, the global leader in allergy and autoimmune disease-related diagnostics, demonstrates how ImmunoCAP Molecular Allergy can help improve the diagnosis and management of food allergy.

26 Jul 2011

GE Healthcare introduces Veo CT image reconstruction technology in Canada

GE Healthcare announced the introduction of a breakthrough Computed Tomography (CT) image reconstruction technology, called Veo, in Canada. The industry's first Model-based Iterative Reconstruction (MBIR) technique, Veo is designed to help physicians deliver accurate diagnoses by enabling high CT image quality at significantly lower dose.

25 Jul 2011